Blood Analysis With Continuous Electromagnetic Molecular Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for continuous monitoring of blood parameters in critically ill patients are limited by the need for repeated blood sampling and lack of real-time measurement of molecular and ionic fluctuations, leading to delayed and potentially inaccurate assessments of physiological and pathological states.
Innovation Solution
A blood analysis system using sequential filtration units with semi-permeable membranes and electromagnetic forces to separate and detect molecular and ionic entities in real-time, without chemical reactions, allowing for precise measurement and correction of blood components before returning them to the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If repeated blood sampling is performed to monitor blood parameters, then real-time information about vital organ functionality can be obtained, but the patient loses blood and the values obtained are not truly real-time
Solution Approach 1:
The patent replaces mechanical/chemical blood sampling methods with electromagnetic detection methods. The system uses electromagnetic fields to detect molecular and ionic parameters in blood continuously without physical extraction, thereby eliminating blood loss while maintaining real-time measurement capability
Solution Approach 2:
The patent implements continuous monitoring of blood parameters through electromagnetic detection, allowing uninterrupted real-time measurement of molecular and ionic fluctuations. This continuous action eliminates the need for discrete repeated sampling, providing constant information about physiological states without cumulative blood loss
2Measurement precision
If ion-selective electrodes and implanted devices are used to monitor blood parameters, then real-time reading of a few molecules can be obtained, but only limited molecular parameters can be monitored
Solution Approach 1:
The patent creates a universal electromagnetic detection system that can monitor multiple molecular and ionic parameters simultaneously. The system uses electromagnetic fields to detect various blood components (ions, molecules, cellular entities) through a single platform, eliminating the limitation of ion-selective electrodes that can only measure specific ions
Solution Approach 2:
The patent changes the detection parameter from electrical potential (ion-selective electrodes) to electromagnetic interaction properties. By measuring electromagnetic absorption, emission, or scattering characteristics, the system can identify and quantify diverse molecular and ionic species based on their unique electromagnetic signatures, greatly expanding monitoring capability
3Measurement precision
If chemical reactions are used to detect blood components, then molecular entities can be measured, but the process is time-consuming and not suitable for continuous real-time monitoring
Solution Approach 1:
The patent replaces chemical reaction-based detection with electromagnetic field-based detection. Electromagnetic interactions occur instantaneously and reversibly, allowing continuous real-time measurement without the time delays inherent in chemical reactions. This enables true continuous monitoring of blood parameters
Solution Approach 2:
The patent employs periodic electromagnetic wave interactions to continuously probe blood components. By using oscillating electromagnetic fields at various frequencies, the system can continuously detect molecular and ionic concentrations without consuming reagents or requiring reaction time, enabling sustained real-time monitoring
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables continuous, real-time monitoring and correction of blood components with minimal adverse effects, providing comprehensive understanding of physiological and pathological states for improved patient management.
Implementation Method 1
sequential filtration units with semi-permeable membranes
Implementation Method 2
electromagnetic forces to separate and detect molecular and ionic entities in real-time
Data Source
AI summary
A blood analysis system comprises: a centrifugation unit to receive blood of a subject to hold first capturing molecules, wherein one first capturing molecule binds with, to chemically capture, one molecule or ion that causes coagulation of the plasma and centrifuge to suspend cellular components with a minimal plasma along with a number of the first capturing molecules; a detection unit to receive the plasma with remaining number of the first capturing molecules and unbound molecules and ions, but without the cellular components, to determine concentration of one or more types of molecules and/or ions; and a correction unit to correct the determined concentration of the one or more types of molecules and/or ions.